Spruce Biosciences, Inc. (SPRB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -8.73M | -6.46M | -5.32M | -8.83M | -12.73M | -20.68M | -9.22M | -11.11M | -14.96M | -11.21M | -12.27M | 1.99M | -11.79M | -11.74M | -8.58M | -9.54M | -11.83M | -9.8M | -7.6M | -9.69M |
| Operating CF Margin % | - | - | - | - | - | -2966.57% | -1532.06% | -689.81% | -747.15% | -388.26% | -399.25% | 92.06% | -600.31% | - | - | - | - | - | - | - |
| Operating CF Growth % | 31.39% | 68.78% | 42.36% | 20.51% | 14.92% | -84.47% | 24.83% | -657.25% | -26.87% | 4.51% | -43.03% | 120.89% | 0.3% | -19.79% | -12.91% | 1.58% | -34.59% | -5.75% | 0% | -106.26% |
| Net Income | -12.27M | -14.65M | -8.21M | -2.07M | -14.04M | -23.56M | -8.67M | -9.18M | -11.63M | -9.95M | -12.35M | -12.82M | -12.79M | -11.14M | -11.4M | -11.87M | -11.76M | -9.18M | -11.45M | -11.77M |
| Depreciation & Amortization | 0 | 5K | 3K | 7K | 6K | 9K | 10K | 12K | 15K | 16K | 17K | 74K | 19K | 129K | 107K | 90K | 21K | 20K | 18K | 95K |
| Stock-Based Compensation | 0 | 1.69M | 415K | -77K | 544K | 961K | 1.14M | 1.69M | 1.56M | 1.22M | 1.12M | 0 | 1.06M | 0 | 0 | 0 | 1.14M | 797K | 1.03M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.1M | 4.09M | 170K | -395K | -93K | 64K | 62K | 63K | 60K | -7K | -81K | 970K | -123K | -2K | 784K | 956K | 138K | -2.42M | 2.1M | 1.01M |
| Working Capital Changes | 2.43M | 2.41M | 2.31M | -6.3M | 857K | 1.85M | -1.76M | -3.69M | -4.97M | -2.49M | -973K | 13.77M | 45K | -721K | 1.93M | 1.28M | -1.36M | 985K | 704K | 972K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.7M | -443K | 579K | -1.07M | 584K | -504K | 1.12M | -1.21M | -1.44M | 180K | 2.21M | -2.5M | 2.02M | -3.26M | 972K | 959K | -1.71M | 0 | 0 | -127K |
| Cash from Investing | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.3M | 13.99M | 22M | 10.48M | 14.57M | -16.89M | 33.51M | -7.49M | -5.98M | -12.34M | -60.83M |
| Capital Expenditures | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7K | 0 | 0 | 0 | -2K | -6K | 0 | -6K | -65K | -3K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 0.23% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43M | 4M | 35.5M | 0 | -5.98M | -12.27M | 0 |
| Cash from Financing | 13.92M | 44.69M | -402K | -400K | -411K | -625K | -405K | -365K | -227K | -552K | -405K | -432K | 50.53M | 36K | -90K | -99K | -88K | 167K | 17K | 176K |
| Debt Issued (Net) | 14.15M | 1.22M | -405K | -406K | -405K | -406K | -405K | -406K | -405K | -406K | -405K | -406K | -405K | 0 | 0 | 0 | 0 | 10K | -10K | 0 |
| Equity Issued (Net) | 0 | 50.07M | 3K | 6K | 0 | 0 | 0 | 52K | 180K | 71K | 0 | 45K | 53.62M | 36K | -50K | -99K | 0 | 0 | 0 | 176K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -230K | -6.59M | 0 | 0 | -6K | -219K | 0 | -11K | -2K | -217K | 0 | -71K | -2.68M | 0 | -40K | 0 | -88K | 157K | 27K | 0 |
| Net Change in Cash | 5.17M | 38.27M | -5.72M | -9.23M | -13.14M | -21.3M | -9.63M | -11.47M | -15.19M | -2.46M | 1.32M | 23.56M | 49.22M | 3.05M | -25.56M | 23.87M | -19.41M | -15.62M | -19.91M | -70.35M |
| Free Cash Flow | -8.74M | -6.46M | -5.32M | -8.83M | -12.73M | -20.68M | -9.22M | -11.11M | -14.96M | -11.21M | -12.28M | 1.99M | -11.79M | -11.74M | -8.58M | -9.55M | -11.83M | -9.8M | -7.66M | -9.7M |
| FCF Margin % | - | - | - | - | - | -2966.57% | -1532.06% | -689.81% | -747.15% | -388.26% | -399.48% | 92.06% | -600.31% | - | - | - | - | - | - | - |
| FCF Growth % | 31.31% | 68.78% | 42.36% | 20.51% | 14.92% | -84.47% | 24.87% | -657.25% | -26.87% | 4.51% | -43.08% | 120.88% | 0.3% | -19.71% | -11.98% | 1.55% | -34.29% | -5.54% | -0.29% | -106.01% |
| FCF per Share | -6.37 | -8.42 | -9.44 | -14.56 | -22.28 | -38.54 | -17.18 | -20.75 | -28.00 | -21.01 | -23.20 | 3.78 | -28.43 | -19.16 | -14.01 | -15.63 | -19.36 | -16.08 | -12.61 | -15.99 |
| FCF Conversion (FCF/Net Income) | 0.71x | 0.44x | 0.65x | 4.27x | 0.91x | 0.88x | 1.06x | 1.21x | 1.29x | 1.13x | 0.99x | -0.16x | 0.92x | 1.05x | 0.75x | 0.80x | 1.01x | 1.07x | 0.66x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53K | 55K | 55K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |